AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
115 hedge funds and large institutions have $437M invested in Aerie Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 108 → 115 (+7)
5% more capital invested
Capital invested by funds: $417M → $437M (+$19.5M)
Holders
115
Holding in Top 10
3
Calls
$28.4M
Puts
$5.19M
Top Buyers
| 1 | +$26.6M | |
| 2 | +$18.1M | |
| 3 | +$11.9M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$6.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.75M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$13.6M | |
| 3 | -$10.5M | |
| 4 |
CCI
Columbus Circle Investors
|
-$5.12M |
| 5 |
Goldman Sachs
New York
|
-$4.56M |